Biggest News Aggregation in the World
📰 Tender Offer Statement News

Page 3 - Tender Offer Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tender Offer Statement. Real-time updates on events, politics, business and more.

MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value

Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...
United States Jean Paul Kress Meagher Flom Eamonn Nolan Julia Neugebauer Thomas Biegi

MorphoSys Enters into Business Combination Agreement to be acquired by Novartis for EUR 2.7 Billion Equity Value

Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis intention to submit a voluntary public...
United States Thomas Biegi Julia Neugebauer Jean Paul Kress German Federal Financial Supervisory Authority Bafin Company Annual Report On Form

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

As previously announced on December 22, 2023, Concentra Biosciences, LLC and its wholly owned subsidiary, Concentra Merger Sub II, Inc. , entered into a merger agreement with Theseus...
United States Concentra Merger Sub Ii Inc Concentra Biosciences Theseus Pharmaceuticals Inc Morrow Sodali Broadridge Corporate Issuer Solutions

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash Tokyo, Japan and Paris, France--(Newsfile Corp. - January 22, 2024) - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A. (NYSE: SQNS) ("Sequans") today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares of Sequans for $0.7575 per ordinary share and American Depositary Shares (&#x2...
France General New York United States South Korea United Kingdom Hong Kong
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

GDEV announces final results of previously announced self tender offer to purchase for cash a minimum of 15,000,000, up to 20,000,000 of its ordinary shares at a purchase price of $2.00 per ordinary share

LIMASSOL, Cyprus, Jan. 19, 2024 -- GDEV Inc. , an international gaming and entertainment company , today announced the final results of the previously announced tender offer by the Company to...
Roman Safiyulin Continental Stock Transfer Trust Company Exchange Commission Globenewswire Inc Df King Co Inc Corporate Development

Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer

Sinovac Biotech Ltd. NASDAQ SVA SINOVAC or the Company a leading provider of biopharmaceutical products in China announced today that its Board of Directors the Board of Directors unanimously determined that the partial tender offer the Tender Offer by Alternative Liquidity Index LP Alternative Liquidity to acquire up to 10000000 common shares of Sinovac the Shares for 0.03 per share in cash the Offer Price is NOT advisable.
United States Helen Yang Sinovac Biotech Ltd Exchange Commission Company Annual Report On Form Trading Of The Company

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science